












































Dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications
Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.





